Results 31 to 40 of about 13,664 (142)

Does TLS Exist in Canine Mammary Gland Tumours? Preliminary Results in Simple Carcinomas

open access: yesVeterinary Sciences, 2022
Neoplastic progression is influenced by the expression of tumour antigens that activate an anti-tumour immune response. Human medical studies show that this body defence is carried out in secondary lymphoid organs (SLOs) but also directly in the tumour ...
Giada Giambrone   +7 more
doaj   +1 more source

A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab

open access: yesIJU Case Reports, 2023
Introduction Although undifferentiated pleomorphic sarcomas are aggressive, a subset of these tumors are immunogenic and may respond to immunotherapy.
Hidetoshi Kokubun   +9 more
doaj   +1 more source

Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies

open access: yesFrontiers in Immunology, 2021
The complex tumor microenvironment (TME) plays a vital role in cancer development and dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) within the TME are well recognized and consist of T cell-rich areas ...
Wendi Kang   +8 more
doaj   +1 more source

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

open access: yesFrontiers in Genetics, 2023
Ovarian cancer (OC) has the lowest survival rate among gynecologic malignancies. Ectopic lymphocyte aggregates, namely tertiary lymphoid structures (TLSs), have been reported as positive biomarkers for tumor prognosis. However, the related gene signature
Yue Hou   +27 more
doaj   +1 more source

Tertiary lymphoid structures and gastric cancer prognosis

open access: yesAPMIS, 2022
Tertiary lymphoid structures (TLSs) are part of immune response against cancer. Their high density and high diameter have been shown to be associated with prognosis in different cancer types. The aim of this study was to examine the prognostic significance of TLS density and diameter in gastric cancer and reproducibility of their assessments.
Kemi, N. (Niko)   +7 more
openaire   +4 more sources

The roles of tertiary lymphoid structures in chronic diseases

open access: yesNature Reviews Nephrology, 2023
Tertiary lymphoid structures (TLSs) are ectopic lymphoid tissues that drive antigen-specific immune responses at sites of chronic inflammation. Unlike secondary lymphoid organs such as lymph nodes, TLSs lack capsules and have their own unique characteristics and functions.
Sato, Yuki   +4 more
openaire   +3 more sources

From Lymphotoxin to Tertiary Lymphoid Structures and Beyond. [PDF]

open access: yesImmunol Rev
ABSTRACT Lymphoid organ development occurs in ontogeny in the absence of antigenic stimulation; inflammation occurs after some immunological insult. These subjects had originally been considered as separate fields of research. Inflammation is due to inflammatory mediators such as lymphotoxin (LT) and its close relative, tumor necrosis
Ruddle NH.
europepmc   +3 more sources

Induction of Secondary and Tertiary Lymphoid Structures in the Skin [PDF]

open access: yesImmunity, 2004
During embryogenesis a developmental program leading to the formation of lymph nodes and Peyer's patches is initiated. We now show that lymph node-like structures as well as tertiary lymphoid structures can ectopically be induced by intradermal injection of newborn lymph node-derived cells.
Cupedo, Tom   +3 more
openaire   +2 more sources

Characteristics of tertiary lymphoid structures in primary cancers [PDF]

open access: yesOncoImmunology, 2013
Tumors are sustained by complex networks of interactions between malignant cells, stromal cells and tumor-infiltrating immune cells. These networks differ from patient to patient in terms of nature, composition and organization as well as with regard to the precise localization of tumor-infiltrating cells.
Goc, Jérémy   +3 more
openaire   +2 more sources

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters

open access: yesFrontiers in Immunology, 2021
The immunotherapeutic treatment of various cancers with an increasing number of immune checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced diseases.
Shuyue Wang, Kun Xie, Tengfei Liu
doaj   +1 more source

Home - About - Disclaimer - Privacy